Healthcare Marketing

//Healthcare Marketing
All Articles
February 4, 2019

Rx: Authenticity, PRN

TL;DR: Authenticity is a popular 21st-century marketing buzzword. But when you pick apart what’s really behind that, you find new opportunities for pharma marketers. Authenticity, transparency, humanity, vulnerability – there are a lot of ways to describe what the public increasingly wants from brands. But simply put: they want

January 18, 2019

Pharmaceutical Company Software Applications Development

On November 20, 2018, the FDA published a Request for Comments about a proposed framework for regulating software applications (“apps”) disseminated by or on behalf of drug sponsors for use with one or more of their prescription drug products. This Intouch POV sets forth the scope of the proposed framework – what is and is not included, provides an overview of the proposed framework itself, and delivers recommendations for pharmaceutical companies involved in developing health-related apps.

November 27, 2018

Copay Accumulator Programs: Cost Shifts and Unintended Consequences

Copay accumulator programs have been a topic of great interest to a number of groups, including managed care organizations, biopharma manufacturers, and patients over the past year. There is no industry standard name for copay accumulators; e.g., UnitedHealthcare and Express Scripts use the terms “Coupon Adjustment: Benefit Plan Protection program”

November 14, 2018

US Government Reasserts Commitment to Ensuring Accessible Websites

The Department of Justice reaffirmed its longstanding policy that Title III of the Americans with Disabilities Act (ADA) applies to websites, though once again, it declined to issue specific regulations on what websites need to do to comply with the law. In this POV from our user experience expert, Amy Toft, we explain the importance of accessibility, how adherence to Title III affects websites, and how making content accessible to all users affects pharma.

Load More Posts